BioTwin’s C$2.5 Million Financing Round

Fasken advised BioTwin in connection with this transaction.On April 8, 2021, BioTwin, a Quebec-based biotechnology company, announced the completion of their pre-seed funding round. The company…

This content is for Standard 1 Year members only.
Login Join Now
Martina Bellini

Author: Martina Bellini

This content is for Standard 1 Year members only.
Login Join Now